Cutting edge proton beam therapy is no better than intensity-modulated radiotherapy for treating people with head and neck cancer, according to new research. The nationwide TORPEdO trial funded by ...

The Institute of Cancer Research and biotechnology company NEOsphere Biotechnologies have announced a new collaboration to accelerate the discovery of molecular glue degrader drugs. The collaboration ...

A new study unveils a fast, low-cost solution for harvesting organoids – miniature three-dimensional (3D) models of human tissue – that could accelerate cancer research and make advanced cell culture ...

We are a world-leading cancer research institute, a charity, and a member institution of the University of London. Public donations and clinical partnerships are helping us to make the discoveries ...

Need to find a specific expert or member of a research group or division? Just search by role, division, name or browse our researchers A-Z.

Dr Li Yuan Chan Clinical Research Fellow: Lymphoma Biology and ImagingHome Research and discoveries Find a researcher ...

The Institute of Cancer Research, London, strongly welcomes the decision by NICE to recommend the targeted breast cancer drug, capivasertib, in combination with fulvestrant, for treating the most ...

Image: DNA sequence. Credit: The Institute of Cancer Research, London. A spit test, where a sample can be collected at home, is more accurate at identifying future risk of prostate cancer for one ...

The Institute of Cancer Research has welcomed new plans to deliver around one million square feet of state-of-the-art research and laboratory space for life-sciences companies in Sutton, south London, ...

A new type of blood test can predict the recurrence of breast cancer in high-risk patients, months or even years before they relapse, research has shown. A team from The Institute of Cancer Research, ...